Cannabis Packaging Systems

GMP-focused guidance on container-closure selection, label control, qualification and lifecycle management.

1 min read · Last reviewed: July 2026 · European Cannabis Institute Editorial Team

Explore this Phase 3 topic

This hub connects focused technical articles with ECI's existing knowledge, quality and professional-development content.

Supporting article

Container-Closure Integrity

Protecting potency, microbiological quality and stability throughout shelf life.

Read article →

Supporting article

Label Reconciliation Under GMP

Controls that reduce mix-ups, issuance errors and packaging-line discrepancies.

Read article →

References

USP <1207> — Package Integrity Evaluation
EU GMP Part I, Chapter 5 — Production
ICH Q1A(R2) — Stability Testing of New Drug Substances and Products

Confirm the current effective version and national applicability before operational, regulatory or clinical use.

Use the knowledge in practice

Apply these principles through ECI training, assessment tools and specialist consultancy support.

Explore courses Contact ECI

Frequently asked questions

What is the main quality objective for cannabis packaging systems?

The objective is to define and maintain controls that ensure identity, consistency, safety and fitness for the intended use.

Which regulatory framework applies?

The applicable framework depends on jurisdiction, intended use, product classification and lifecycle stage. EU GMP, pharmacopoeial and product-specific requirements may all be relevant.

Is finished-product testing sufficient?

No. Testing is only one element of assurance. Supplier controls, process understanding, qualification, in-process monitoring and data governance are also required.

How should specifications be set?

Specifications should be scientifically justified using process capability, safety considerations, stability data, pharmacopoeial requirements and the intended clinical or technical use.

Why is trending important?

Trending can reveal gradual drift, supplier changes or method deterioration before individual results breach an acceptance limit.